ArriVent BioPharma (AVBP) Earnings Date, Estimates & Call Transcripts $17.99 -0.55 (-2.97%) Closing price 04:00 PM EasternExtended Trading$18.52 +0.53 (+2.92%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ArriVent BioPharma Earnings Summary ArriVent BioPharma released Q1 2025 earnings on May 12, 2025, reporting an EPS of -$1.90, which missed the consensus estimate of -$0.66 by $1.24. With a trailing EPS of -$3.77, ArriVent BioPharma's earnings are expected to decrease next year, from ($2.74) to ($3.22) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 12) -$0.66 Actual EPS (May. 12) -$1.90 Missed By -$1.24 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)AVBP Upcoming EarningsArriVent BioPharma's Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Thursday, August 14, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get ArriVent BioPharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ArriVent BioPharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAVBP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. ArriVent BioPharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.78-$0.70-$0.74Q2 20253-$0.78-$0.52-$0.68Q3 20253-$0.83-$0.60-$0.70Q4 20253-$0.78-$0.68-$0.72 FY 2025 11 -$3.17 -$2.50 -$2.84 Q1 20261-$0.69-$0.69-$0.69Q2 20261-$0.73-$0.73-$0.73Q3 20261-$0.76-$0.76-$0.76Q4 20261-$0.80-$0.80-$0.80 ArriVent BioPharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/12/2025Q1 2025-$0.66-$1.90 -$1.24-$1.90--3/3/2025Q4 2024-$0.78-$0.60+$0.18-$0.61--8/14/2024--$0.65-$0.65--$0.65--5/8/2024Q1 2024-$0.84-$0.70+$0.14-$0.70-- ArriVent BioPharma Earnings - Frequently Asked Questions When is ArriVent BioPharma's earnings date? ArriVent BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on AVBP's earnings history. Did ArriVent BioPharma beat their earnings estimates last quarter? In the previous quarter, ArriVent BioPharma (NASDAQ:AVBP) missed the analysts' consensus estimate of ($0.66) by $1.24 with a reported earnings per share (EPS) of ($1.90). Learn more on analysts' earnings estimate vs. AVBP's actual earnings. How much profit does ArriVent BioPharma generate each year? ArriVent BioPharma (NASDAQ:AVBP) has a recorded net income of -$80.49 million. AVBP has generated -$3.77 earnings per share over the last four quarters. What is ArriVent BioPharma's EPS forecast for next year? ArriVent BioPharma's earnings are expected to decrease from ($2.74) per share to ($3.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Crinetics Pharmaceuticals Earnings Ultragenyx Pharmaceutical Earnings Organon & Co. Earnings Catalyst Pharmaceuticals Earnings Mirum Pharmaceuticals Earnings Bausch Health Cos Earnings NewAmsterdam Pharma Earnings Amneal Pharmaceuticals Earnings Recursion Pharmaceuticals Earnings Apellis Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:AVBP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts